AKT1 and Parkinson disease: Nlrc5 deficiency attenuates glial activation by inhibiting the NF-κB and MAPK signaling pathways and reinforces neuronal protection by enhancing the activation of NF-κB and AKT in PD-related cell models (Fig. 10, Additional file 1: Fig. S8).